The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy. Solomon DH, Xu C, Collins J, Kim SC, et al. Arthritis Res Ther 2021;23:26.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Solomon DH, Xu C, Collins J, Kim SC, et al. The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy. Arthritis Res Ther 2021;23:26.
PMID: 33446261